Inhibrx Biosciences INBX Growth Metrics (2023-2026)

NASDAQ INBX
$121.17 -1.09 (-0.89%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Inhibrx Biosciences Quarterly Growth Metrics

Periods 11 quarters
Latest Jun 2026

Inhibrx Biosciences growth metrics data for the quarter ended Jun 2026. These growth metrics cover 11 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Growth Ratios
EBITDA Margin Growth (1y) -2.31M-4.45M15.88M
EBITDA Margin (QoQ) 9.93M3.31M
EBIT Margin Growth (1y) -2.31M-4.45M15.88M
EBIT Margin (QoQ) 9.93M3.31M
EBT Margin Growth (1y) 201.48M-4.22M-186.02M
EBT Margin (QoQ) 11.33M3.79M
FCF Margin Growth (1y) -4.02M5.72M
FCF Margin (QoQ) 4.24M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -473.91%-75.70%70.95%35.24%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y) -2.59%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -7.54%-90.92%15.43%-230.52%45.34%-21.90%8.66%
Net Margin Growth (1y) 201.49M-4.22M-186.02M
Net Margin (QoQ) 11.33M3.79M
Operating Margin Growth (1y) -2.31M-4.45M15.88M
Operating Margin (QoQ) 9.93M3.31M
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -0.08M-0.09M-0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.02M-0.00M-0.09M-762.00-685.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.01M0.01M-0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) -0.00M0.00M0.01M-836.00-835.00
Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y) 0.01M0.01M-0.00M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ) -0.00M0.00M0.01M-860.00-895.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -2.31M1.86M-4.45M15.88M0.90M4.03M-0.75M
Return on Sales [ROS] Growth (3y)ROS Growth (3y) 12.82M
Return on Sales [ROS] (QoQ)ROS (QoQ) 9.93M3.31M14.09M-3.00M-0.89M0.14M